• Please log in or register to access this feature.

Tumor Immunology

You have full text access to this OnlineOpen article

High frequencies of circulating melanoma-reactive CD8+ T cells in patients with advanced melanoma

  1. Anne Letsch1,
  2. Ulrich Keilholz1,
  3. Dirk Schadendorf2,
  4. Dirk Nagorsen1,
  5. Alexander Schmittel1,
  6. Eckhard Thiel1,
  7. Carmen Scheibenbogen MD1,*

Article first published online: 28 JUL 2000

DOI: 10.1002/1097-0215(20000901)87:5<659::AID-IJC7>3.0.CO;2-7

Issue

International Journal of Cancer

International Journal of Cancer

Volume 87, Issue 5, pages 659–664, 1 September 2000

Additional Information

How to Cite

Letsch, A., Keilholz, U., Schadendorf, D., Nagorsen, D., Schmittel, A., Thiel, E. and Scheibenbogen, C. (2000), High frequencies of circulating melanoma-reactive CD8+ T cells in patients with advanced melanoma. Int. J. Cancer, 87: 659–664. doi: 10.1002/1097-0215(20000901)87:5<659::AID-IJC7>3.0.CO;2-7

Author Information

  1. 1

    Universitätsklinikum Benjamin Franklin, Medizinische Klinik III (Hämatologie, Onkologie und Transfusionsmedizin), Freie Universität Berlin, Berlin, Germany

  2. 2

    Klinische Kooperationseinheit für Dermatoonkologie (DKFZ), Klinikum Mannheim, Universität Heidelberg, Mannheim, Germany

*Universitätsklinikum Benjamin Franklin, Medizinische Klinik III, Hämatologie, Onkologie und Transfusionsmedizin, Hindenburgdamm 30, 12200 Berlin, Germany. Fax: 49-30-8445 4468

Publication History

  1. Issue published online: 28 JUL 2000
  2. Article first published online: 28 JUL 2000
  3. Manuscript Accepted: 10 MAR 2000
  4. Manuscript Revised: 3 MAR 2000
  5. Manuscript Received: 15 OCT 1999

Funded by

  • Deutsche Forschungsgemeinschaft. Grant Number: Sche 4781/1-3
  • Mildred-Scheel-Stiftung. Grant Number: 10-1072-Ke2
  • EORTC Melanoma Cooperative Group

SEARCH

SEARCH BY CITATION

ARTICLE TOOLS

View Full Article (HTML) Get PDF (99K)

REFERENCES

  • Anichini, A., Mortarini, R., Macalli, C., Sqarcina, P., Fleischhauer, K., Mascheroni, L. and Parmiani, G., Cytotoxic T cells directed to tumor antigens not expressed on normal melanocytes dominate HLA-A2.1-restricted immune repertoire to melanoma. J. Immunol., 156, 208-217 (1996).
  • Di Fabio et al., Quantification of human influenza virus-specific cytotoxic T lymphocytes: correlation of cytotoxicity and increased number of IFNγ producing CD8+ T cells. Int. Immunol., 6, 11-19 (1994).
  • Faure, F., Even, J. and Kourisly, P., Tumor-specific immune response: current in vitro analyses may not reflect the in vivo immune status. Crit. Rev. Immunol., 18(1-2), 77-86 1998).
  • Hamann, D., Baars, P., Rep, M., Hooibrink, B., Kerkhof-Garde, S., Klein, M. and Van Lier, R., Phenotypical and functional separation of memory and effector human CD8+ T cells. J. Exp. Med., 186, 1407-1418 (1997).
  • Herr, W., Schneider, J., Lohse, A. W., Meyer zum Bueschenfelde, K.-H. and Woelfel, T., Detection and quantification of blood-derived CD8+T lymphocytes secreting TNFa in response to HLA-A2.1-binding melanoma and viral peptide antigens. J. Immunol. Method. 191, 131-143 (1996).
  • Hom, S., Schwarztentrubber, D., Rosenberg, S. and Topalian, S., Specific release of cytokines by lymphocytes infiltrating human melanomas in response to shared antigens. J. Immunother. 13, 18-30 (1993).
  • Marincola, F., The multiple ways to tumor tolerance. J. Immunother. 20(3), 178-179 1997).
  • Mazzocchi, A., Storkus, W., Traversari, C., Tarsini, P., Maeurer, M., Rivoltini, L., Vegetti, C., Belli, F., Anichini, A., Parmiani, G. and Castelli, C., Multiple melanoma-associated epitopes recognized by HLA-A3-restricted CTLs and shared by melanomas but not melanocytes. J. Immunol., 157(7), 3030-3038 1996).
  • Miyahira, et al., Quantification of antigen specific CD8+ T cells using an ELISPOT assay. J. Immunol. Methods, 181, 45-54 (1995).
  • Lee, P., Yee, C., Savage, P., Fong, L., Brockstedt, D., Weber, J., Johnson, D., Swetter, S., Thompson, J., Greenberg, P., Roederer, M. and Davis, M., Characterisation of circulating T cells specific for tumor-associated antigens in melanoma patients. Nature (Med.), 5(6), 677-685 1999).
  • Robbins, P. and Kawakami, Y., Human tumor antigens recognized by T cells. Curr. Opin. Immunol., 8, 628-636 (1996).
  • Scheibenbogen, C., Lee, K. H., Mayer, S., Stefanovic, S., Moebius, U., Herr, W., Rammensee, H. G. and Keilkolz, U., A sensitive Elispot assay for detection of CD8+ lymphocytes specific for HLA class I-binding peptide epitopes derived from influenza proteins in the blood of healthy donors and melanoma patients. Clin. Cancer Res. 3, 221-226 (1997).
  • Slingluff, C., Graham, D., Skipper, J., Kittlesen, D., Deacon, D., Colella, T., Harthun, N., Huczko, E., Darrow, T., Innes, D., Golden, W. and Engelhard, V., Immunologic escape variant melanomas with normal MHC expression and antigen processing lack multiple melanocytic differentiation antigens. J. Immunother., 19, 460 (1996).
View Full Article (HTML) Get PDF (99K)